Persistent weakness in US
IN-LINE QUARTER BUT EX-TARO US REMAINS WEAK Sun Pharma management reiterated its prior commentary and maintained that US generics environment..
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel https://t.me/Investment..
Sun Pharmaceutical Industries Ltd’s second quarter figures have outrun estimates, showing that the firm is getting back on the recovery path. The stock surged i..
The company reported standalone net profit during the quarter stood at Rs 823.16 crore compared to net loss of Rs 906.42 crore in the previous year quarter. Net revenue o..
BENGALURU - Indian drugmaker Sun Pharmaceutical Industries Ltd said on Wednesday it would introduce some of its cancer treatment drugs in China through Britain'..
Sun Pharmaceutical Industries Limited (SUNPHARMA)
We’re seeing a mixed trend in pharma space and SUNPHARMA has been trading in a prolong downtrend. It’s cu..
Specialty Drug Cequa Launched in the US
Sun Pharmaceutical Industries (SUNP) has launched ophthalmic specialty Novel/NDA drug Cequa (API: cyclosporine; strength: 0.09%..
Strong bottom line benefitted by one time gain
Sun Pharma is India’s top drug maker and world’s fifth largest specialty generic pharmaceutical company. Th..
No improvememt in broader US business; margin flat yoy
Sun Pharma management indicated on the earnings call it has seen no improvement in broader U..
Better Than Expected Performance in 1QFY20; Maintain BUY
Sun Pharmaceutical Industries (SUNP) has reported higher-than-expected performance in 1QFY20 led by healthy gr..
Q1 core sales in line; Fx gain, lower SGA, oneoffs beat earnings
SUNP’s adj sales, adj. EBITDA and adj. PAT increased by 10%, 14% and 1% QoQ respectively due to ..
Positive outlook persists
We maintain BUY on SUNP following a beat to our estimates. Our TP is at Rs 545 (22x FY21E EPS). The execution in specialty segment is crucial..
Accelya Solutions In Q4 net profit up 32.35% at Rs 24.71 cr
US dollar rises after Fed policy meeting
Rupee rises by 12 paise to Rs 69.05 against dollar
BSNL to offer more data, validity under select prepaid plans
Infosys signs agreement with U.S. IRS; sees lower tax rate
India asks Japan to reduce trade surplus before Abe`s visit
Market Quote by Mr. Nagaraj Shetti, HDFC securities 10 December 2019
Ted Baker CEO exits as Black Friday profit warning pummels shares
Bank of Baroda lowers MCLR lending rates by 20 bps
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface